Interesting share price action. Must be the first time in ASX history that an FDA approval announcement results in a share price dropping
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx, page-22
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #